INVITROCUE

In News

3 companies fined nearly $1.2m in total for financial reporting breaches - Accounting Times

Accounting Times - Apr 01, 2026

Singapore entrepreneur sold family home twice to fund startups, and gave up S$750,000 annual salary - Yahoo Finance Singapore

Yahoo Finance Singapore - Feb 27, 2024

The Resilient Journey of Invitrocue – Pioneering Biotech Solutions and Transforming Lives - SME & Entrepreneurship Magazine

SME & Entrepreneurship Magazine - Feb 15, 2024

Invitrocue & GIS Establish Joint Cancer Lab - Asian Scientist Magazine

Asian Scientist Magazine - Aug 04, 2017

Biotech firm offers personalized cancer drug test to Hong Kong - The Standard (HK)

The Standard (HK) - Jun 28, 2021

Invitrocue leads market with disruptive technology and personalised oncology solutions - proactiveinvestors.com.au

proactiveinvestors.com.au - May 19, 2019

Will this work for me? A test that identifies drugs one’s cancer responds to - The Business Times

The Business Times - Jun 06, 2024

Invitrocue Limited (ASX:IVQ) - intelligentinvestor.com.au

intelligentinvestor.com.au - Sep 25, 2019

Me & My Money: Entrepreneur sells his home to fund biotech start-up - The Straits Times

The Straits Times - Apr 21, 2024

Invitrocue Limited (ASX: IVQ) - Share Price - intelligentinvestor.com.au

intelligentinvestor.com.au - Feb 05, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment